Boston Scientific Corp (BSX)vsDiamondback Energy Inc (FANG)
BSX
Boston Scientific Corp
$53.93
-4.67%
HEALTHCARE · Cap: $84.08B
FANG
Diamondback Energy Inc
$188.70
-0.92%
ENERGY · Cap: $53.58B
Smart Verdict
WallStSmart Research — data-driven comparison
Boston Scientific Corp generates 42% more annual revenue ($20.61B vs $14.47B). BSX leads profitability with a 17.3% profit margin vs 2.0%. BSX appears more attractively valued with a PEG of 0.68. BSX earns a higher WallStSmart Score of 71/100 (B).
BSX
Strong Buy71
out of 100
Grade: B
FANG
Hold41
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-16.7%
Fair Value
$46.22
Current Price
$53.93
$7.71 premium
Margin of Safety
+44.6%
Fair Value
$305.11
Current Price
$188.70
$116.41 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 100.0% YoY
Large-cap with strong market position
Growing faster than its price suggests
Strong operational efficiency at 20.6%
Reasonable price relative to book value
Large-cap with strong market position
Areas to Watch
No major concerns identified
ROE of 0.5% — below average capital efficiency
2.0% margin — thin
Weak financial health signals
Expensive relative to growth rate
Comparative Analysis Report
WallStSmart ResearchBull Case : BSX
The strongest argument for BSX centers on EPS Growth, Market Cap, PEG Ratio. Profitability is solid with margins at 17.3% and operating margin at 20.6%. Revenue growth of 11.6% demonstrates continued momentum.
Bull Case : FANG
The strongest argument for FANG centers on Price/Book, Market Cap.
Bear Case : BSX
No major red flags identified for BSX, but monitor valuation.
Bear Case : FANG
The primary concerns for FANG are Return on Equity, Profit Margin, Piotroski F-Score. A P/E of 196.3x leaves little room for execution misses. Thin 2.0% margins leave little buffer for downturns.
Key Dynamics to Monitor
BSX profiles as a mature stock while FANG is a value play — different risk/reward profiles.
BSX carries more volatility with a beta of 0.62 — expect wider price swings.
BSX is growing revenue faster at 11.6% — sustainability is the question.
FANG generates stronger free cash flow (895M), providing more financial flexibility.
Bottom Line
BSX scores higher overall (71/100 vs 41/100), backed by strong 17.3% margins and 11.6% revenue growth. FANG offers better value entry with a 44.6% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Boston Scientific Corp
HEALTHCARE · MEDICAL DEVICES · USA
Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Diamondback Energy Inc
ENERGY · OIL & GAS E&P · USA
Diamondback Energy is a company engaged in hydrocarbon exploration and headquartered in Midland, Texas.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?